LFCR · Lifecore Biomedical Inc
United States · RS rating 72 · As of 2026-11-03
| Price | 6.42 USD |
|---|---|
| 1-day change | +0.5% |
| RS rating (overall / 1M / 3M / 12M) | 72 / 52 / 94 / 43 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 30 / 35 / 28 |
| Industry group (rank) | Medical-Ethical Drugs (94) |
| EPS growth Q/Q | -383.3% |
| Sales growth Q/Q | -14.6% |
| Distance from 52-week high | +27.2% |
| Market cap (USD) | $184.4M |